Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Utility of Preoperative FDG-PET/CT Scanning Prior to Primary Chemoradiation Therapy to Detect Retroperitoneal Lymph Node Metastasis in Patients With Locoregionally Advanced Carcinoma of the Cervix (IB2, IIA ≥ 4 CM, IIB-IVA) or Endometrium (Grade 3 Endometrioid Endometrial Carcinoma; Serous Papillary Carcinoma, Clear Cell Carcinoma, or Carcinosarcoma (Any Grade); and Grade 1 OR 2 Endometrioid Endometrial Carcinoma With Cervical Stromal Involvement Overt in Clinical Examination or Confirmed by Endocervical Curettage

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00416455
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:13.694616+00:00
Published At
2015-12-14T00:00:00+00:00
Record Updated At
2019-07-23
Results Posted At
2015-12-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cervical Adenocarcinoma", "Cervical Adenosquamous Cell Carcinoma", "Cervical Small Cell Carcinoma", "Cervical Squamous Cell Carcinoma", "Endometrial Clear Cell Carcinoma", "Endometrial Papillary Serous Carcinoma", "Stage I Endometrial Carcinoma", "Stage IB Cervical Cancer", "Stage II Endometrial Carcinoma", "Stage IIA Cervical Cancer", "Stage IIB Cervical Cancer", "Stage III Cervical Cancer", "Stage III Endometrial Carcinoma", "Stage IVA Cervical Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-07-23"
protocolSection.identificationModule.nctId
"NCT00416455"
protocolSection.identificationModule.officialTitle
"Utility of Preoperative FDG-PET/CT Scanning Prior to Primary Chemoradiation Therapy to Detect Retroperitoneal Lymph Node Metastasis in Patients With Locoregionally Advanced Carcinoma of the Cervix (IB2, IIA \u2265 4 CM, IIB-IVA) or Endometrium (Grade 3 Endometrioid Endometrial Carcinoma; Serous Papillary Carcinoma, Clear Cell Carcinoma, or Carcinosarcoma (Any Grade); and Grade 1 OR 2 Endometrioid Endometrial Carcinoma With Cervical Stromal Involvement Overt in Clinical Examination or Confirmed by Endocervical Curettage"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2015-12-14"

Study condition terms

  • Cervical Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Cervical Adenosquamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Cervical Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Cervical Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Endometrial Clear Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Endometrial Papillary Serous Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Endometrial Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IB Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Endometrial Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IIA Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIB Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Endometrial Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Cervical Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.